GB Group Ord Shs GBGPF

Why I think cannimed is lagging behind in price.

[Bobthebuilddr]

So at a quick comparison with aurura and aph, you can see a large difference in market cap. The reason for this imo, is there future growth plan. Although I do think that cmed will be tops in the industry for medical, the market is looking for future gains. An example is aph. 1 million sq feet by 2019. ACB will have 800k in late 2017. Both have current market caps over 700million based solely on those 2 factors imo. In order for cmed to grow they need to look at recreational market and grow in a massive way. The current share price is outstanding as it leaves room for a PP and not crush the shareholder value. A PP of around 60-90 million could allow them to build another 600,000+ and be in the top stocks and only add 10 million or so shares to the outstanding balance which still makes them the least diluted / lowest outatanding balance stock in the sector. As great as the medical market will be in a couple years, and gel caps and wafers will bring is great revenue, the recreational market shouldn't be ignored. I'm hoping they have something in the works to meet that demand. The company looks great and is set up to do great things, all it needs is a bit of a shove forward to get the markets attention. And a big expansion would do just that.